During the past decade, one of the most striking discoveries in the treatment of major depression was the clinical finding that a single infusion of a sub-anesthetic dose of the N-methyl-D-aspartate receptor antagonist ketamine produces a rapid (i.e. within a few hours) and long-lasting (i.e. up to two weeks) antidepressant effect in both treatment-resistant depressed patients and in animal models of depression. Notably, converging clinical and preclinical evidence support that responsiveness to antidepressant drugs is sex-differentiated. Strikingly, research regarding the antidepressant-like effects of ketamine has focused almost exclusively on the male sex. Herein we report that female C57BL/6J stress-naïve mice are more sensitive to the rapid and the sustained antidepressant-like effects of ketamine in the forced swim test (FST). In particular, female mice responded to lower doses of ketamine (i.e. 3 mg/kg at 30 min and 5 mg/kg at 24h post-injection), doses that were not effective in their male counterparts. Moreover, tissue levels of the excitatory amino acids iv glutamate and aspartate, as well as serotonergic activity, were affected in a sexdependent manner in the prefrontal cortex and the hippocampus, at the same timepoints. Most importantly, a single injection of ketamine (10 mg/kg) induced sexdependent behavioral effects in mice subjected to the chronic mild stress (CMS) model of depression. Intriguingly, female mice were more reactive to the earlier effects of ketamine, as assessed in the open field and the FST (at 30 min and 24 h post-treatment, respectively) but the antidepressant potential of the drug proved to be longer-lasting in males, as assessed in the splash test and the FST (days 5 and 7 posttreatment, respectively). Taken together, present data revealed that ketamine treatment induces sex-dependent rapid and sustained neurochemical and behavioral antidepressant-like effects in stress-naïve and CMS-exposed C57BL/6J mice.
INTRODUCTION
According to the World Health Organization (WHO), by 2020 major depression is expected to rise to become the number two contributor to the global burden of disease (Collins et al., 2011) . Current treatments for depressive disorders are only partly effective and patients who suffer from treatment-resistant depression require innovative pharmacological agents with novel mechanisms of action. Of note, women experience major depression at roughly twice the rate of men (Holden, 2005 , Marcus et al., 2005 , Grigoriadis and Robinson, 2007 and respond differentially to different types of antidepressant treatment (Young et al., 2009 ). The neurobiological mechanisms underlying these differences remain a largely neglected area of research and current treatments are based almost exclusively on research in male subjects (Beery and Zucker, 2011) .
During the past decade, one of the most striking discoveries in the treatment of major depression was the clinical finding that a single infusion of a sub-anesthetic dose of the N-methyl-D-aspartate receptor (NMDAR) antagonist ketamine produces a rapid (i.e. within a few hours) and sustained (i.e. lasting from one day up to two weeks) antidepressant effect in both treatment-resistant depressed patients and in animal models of depression (Skolnick et al., 2009) . In this context, administration of a single dose of ketamine in rodents has been shown to induce effects in antidepressant-predictive behavioral tasks including the forced swim test (FST) and the chronic mild stress (CMS) model of depression (Garcia et al., 2008 , Maeng et al., 2008 , Engin et al., 2009 , Li et al., 2010 , Autry et al., 2011 , Bechtholt-Gompf et al., 2011 , Li et al., 2011 . Of note, CMS is an ideal paradigm with which to screen the antidepressant-like effects of novel pharmacotherapeutic agents in rodents and possibly the most valid method for the preclinical investigation of the antidepressant-like effects of ketamine (Browne and Lucki, 2013, Franceschelli et al., 2014) . Indeed, the discovery of ketamine's antidepressant-like effects has reshaped and revolutionized antidepressant drug discovery (Browne and Lucki, 2013, Duman, 2014) and the behavioral and neurobiological mechanisms underlying its rapid and sustained antidepressant-like effects are under intensive investigation.
Converging clinical and experimental evidence from our group and others support that responsiveness to antidepressant drugs is sex-differentiated (Sloan and Kornstein, 2003 , Marcus et al., 2005 , Pitychoutis et al., 2010 , Dalla et al., 2011 , Pitychoutis et al., 2012 . Strikingly, research regarding the antidepressant-like effects of ketamine has focused almost exclusively on the male sex. Recently, Carrier and Kabbaj (2013) provided the first evidence that female Sprague-Dawley rats are more sensitive to the rapid antidepressant-like effects of a single injection of ketamine in the FST, as they respond to a lower dose (i.e. 2.5 mg/kg), a dose that does not induce antidepressant-like effects in male rats. C57BL/6J
is the most widely used inbred mouse strain and has been widely used in preclinical ketamine research (Autry et al., 2011, Browne and Lucki, 2013) . To our knowledge, sex differences in response to ketamine have never been reported in this strain.
Despite the fact that both the glutamatergic and the serotonergic systems have been implicated in ketamine's mechanism of action (Gigliucci et al., 2013 , Nishitani et al., 2014 , Yamanaka et al., 2014 , the intricate neurochemical mechanisms underlying its effects remain elusive. For instance, microdialysis studies report that antidepressant-relevant doses of ketamine increase extracellular levels of the excitatory amino acid glutamate in the prefrontal cortex (PFC) due to a possible local disinhibition of ΰ-aminobutyric acid (GABA)-ergic interneurons (Lorrain et al., 2003 , Duman, 2014 . However, whether this effect is restricted to certain brain regions is not known. Notably, chronic treatment with conventional antidepressants has been shown to affect the serotonergic system and the levels of excitatory amino acids, glutamate and aspartate, in the prefrontal cortex (PFC) and the hippocampus (HIPP) in a sex-dependent manner (Kokras et al., 2009 , Pitychoutis et al., 2012 . However, putative sex differences in the neurochemical effects of ketamine have never been investigated.
In the present study we sought to investigate whether administration of a single dose of ketamine would induce sex-dependent behavioral and neurochemical effects in C57BL/6J mice. Our results show that female stress-naïve mice are more sensitive to both the rapid (i.e. at 30 min) and the sustained (i.e. at 24 h)
antidepressant-like effects of ketamine in the FST. Moreover, ketamine treatment (10 mg/kg) induced region-dependent and sex-differentiated neurochemical effects in the PFC and the HIPP. Most importantly, a single injection of ketamine (10 mg/kg) induced intriguing sex-dependent behavioral effects in mice subjected to CMS for five weeks. Specifically, female CMS-exposed mice were more reactive to the earlier effects of ketamine, but the antidepressant potential of the drug proved to last longer in males.
METHODS

Animals
Adult male and female C57BL/6J mice used in this study were bred at the Vivarium of the University of Dayton from a mouse colony originally obtained from the Jackson Laboratory (ME, USA under standard laboratory conditions and were given access to food and water ad libitum, unless otherwise specified. All efforts were made to minimize the number of animals used and their suffering.
Drug treatment
Mice received a single injection of 3, 5 or 10 mg/kg body weight (BW) of ketamine hydrochloride (Henry-Schein; NY; USA) or vehicle (VEH; 0.9% NaCl).
Drugs were injected intraperitoneally (i.p.) in a volume of 10 mL/kg of body weight.
The sub-anesthetic doses of ketamine implemented, times and route of administration selected are commonly used to screen for the antidepressant-like effects of ketamine in preclinical rodent models (Browne and Lucki, 2013) .
Experimental Design
In the current study we investigated whether behavioral and neurochemical responses of male and female C57BL/6J mice are sex-differentiated in three independent experiments. In an initial dose-dependent study (Experiment #1) we questioned whether naïve male and female mice would show differential sensitivity to increasing doses of ketamine in the FST, an antidepressant-predictive animal model.
The 10 mg/kg ketamine dose that reliably induced both rapid and sustained antidepressant-like effects in the FST in both sexes was further implemented for neurochemical assessments in naïve mice (Experiment #2). Lastly, in Experiment #3, we investigated the antidepressant-like behavioral effects of a single 10 mg/kg dose of ketamine in "depressed" mice subjected to the chronic mild stress (CMS) model of depression. Given our aim to determine whether there is a basic sex difference in the way males and females respond to ketamine, the female reproductive state was not taken into account (McCarthy et al., 2012) . Since it is generally agreed that the first stage of any sex-difference study should be a comparison of gonadally intact adult females and males (Greenspan et al., 2007) , a two-group design (males and females) was implemented for testing for sex-differentiated traits, as in previous studies (Pitychoutis et al., 2012, Carrier and Kabbaj, 2013) . Based on the dose-response FST study conducted in Experiment #1, the 10 mg/kg dose of ketamine was administered in the CMS experiment, as this dose was proven to induce rapid and sustained antidepressant-like effects in both sexes.
Behavioral testing
Forced swim test (FST)
The FST was conducted as previously described (Adachi et al., 2008 , Autry et al., 2011 , Stratinaki et al., 2013 . Specifically, swim sessions were conducted by placing mice individually in a glass 4 L beaker filled with 3 L of water (23-25 o C).
Mice were gently placed in water and the duration of immobility (i.e. the time that mice spent making only the required movements to keep their head above water) was measured during the last 4 min of a 6-min trial. Mice were then removed from water, dried and placed in their home cage. In the CMS experiment, mice were subjected to the FST twice, based on the recent observation that C57BL/6 mice display stable behavior upon repeated FST exposure (Pozzi et al., 2014) .
Chronic mild stress (CMS) model of depression
Male and female C57BL/6J mice (8 weeks of age) were housed in individual cages and allowed for 2 weeks to habituate before beginning experimentation. Mice were subjected to 5 weeks of CMS after the protocol described by Elizalde et al. (2008) , with minor modifications. Briefly, the following stressors (two-three in any 24 h period) were applied: stroboscopic illumination (in dark 8 h), white noise (an untuned radio, 4 h), cage tilt 45° (8 h), soiled bedding (200 mL of water per cage; 6 h), paired housing (with new partner 2 h), food and water deprivation (8 h, not prior to sucrose consumption test), and overnight illumination and removal of nesting material (12 h) (Elizalde et al., 2008) . Hedonic status was evaluated by weekly monitoring of sucrose intake, as indicated in the respective section. Following 5 weeks of CMS exposure and anhedonia establishment, both CMS and control mice were matched into VEH and ketamine groups (N = 6-8 mice/group) according to their sucrose intake.
Spontaneous locomotor activity
Mice 
Sucrose consumption
Hedonic status was evaluated by weekly monitoring of sucrose intake, as previously described (Elizalde et al., 2008 , Elizalde et al., 2010 . After 2 weeks of initial habituation to single housing, mice were trained to consume a 2.5 % sucrose solution every other night (from 7:00 PM to 10:00 AM). Following the establishment of sucrose intake baseline, all mice were divided into CMS and control groups matched for their relative sucrose consumption, and the CMS application started.
Once per week, mice were given a 15-h exposure to the sucrose solution in their home cage as described above, without prior food or water deprivation. Body weight measurements were taken weekly in both CMS and control mice and the relative sucrose intake was calculated as absolute intake (g) per mouse body weight.
Marble Burying
This is a test suggested to measure anxiety/compulsive behavior in mice.
Marble burying behavior is attenuated by low doses of benzodiazepines, and on the basis of this pharmacological evidence, it is suggested that mice bury marbles because marbles evoke anxiety (Deacon, 2006) . Mice were placed in a clean cage and 20 glass marbles of 15mm in diameter were placed in 5 rows, in a regular pattern evenly spaced from one another on the surface of approximately 5 cm-thick standard wood bedding. The test duration was 30 min and the number of marbles buried (>50% marble covered by bedding material) was recorded (Thomas et al., 2009 ).
Splash test
The splash test was performed during the dark period under red lighting, as previously described (Nollet et al., 2013) . In this test, a 10% sucrose solution was sprayed on the dorsal coat of mice. The sprayer allowed delivery of a fixed volume (about 0.7 ml) of sucrose solution (each mouse received two sprays). The duration of grooming was recorded during five minutes after the vaporization of sucrose solution.
Exposure to CMS has been shown to decrease grooming duration in the splash test, and this is reversed by chronic antidepressant treatment (Nollet et al., 2013) .
Neurochemical analysis with high performance liquid chromatography (HPLC)
Following decapitation, the brain was carefully removed from the skull and the brain regions of interest were rapidly isolated on ice. After weighing, the tissue was homogenized and deproteinized in 0.2 N perchloric acid solution, as previously described was set at +50 mV and the second electrode at +350 mV, column temperature was set at 32 o C and the flow rate was constant at 0.5 mL/min. The excitatory amino acids glutamate and aspartate were measured as their OPA/ίME derivatives (Donzanti and Yamamoto, 1988) . The composition of the amino acid mobile phase was 100mM release, reuptake, and/or metabolism of serotonin (Commissiong, 1985 , Elhwuegi, 2004 ).
Statistical analysis
All data are presented as means±SEM. Statistical analyses were performed using the SPSS v.21 statistical software (SPSS Inc., Chicago, IL, USA). Data were analyzed by one-or two-way analysis of variance (ANOVA) for each sex, with stress (CMS vs. control) and drug treatment (Ketamine vs. VEH) as independent factors or by repeated-measures ANOVA followed by pair-wise comparisons. Homogeneity of covariance was assessed with the Mauchly's test of sphericity. In cases where sphericity was violated, the ANOVA F was modified according to the GreenhouseGeisser correction to make it more conservative. The level of statistical significance was set at 0.05.
RESULTS
Experiment #1
Females are more sensitive to the rapid and the sustained antidepressant-like effects of ketamine in the FST Male and female C57BL/6J mice displayed differential sensitivity to the rapid Table 1) .
Experiment #3
CMS exposure induced anhedonia in both sexes
Following CMS exposure, anhedonia was established in both sexes (Fig. 4a 
CMS-induced anhedonia and anxiety were not reversed by ketamine treatment
Ketamine treatment did not reverse CMS-induced anhedonia in either sex. In particular, two-way repeated measures ANOVAs (baseline vs. day 6) revealed significant main effects of stress in both male and female mice [F(1,24) = 8.283, p = .008; F(1,24) = 13.537, p < .001] (Fig. 4c,d) . Additional 2-way ANOVAs revealed that sucrose consumption at baseline was lower in male and female CMS-exposed mice, (Fig. 5b) (Fig. 5d) . Ketamine treatment did not affect open-field behavior in male mice (Fig. 5a,c) .
Ketamine reduced immobility in the FST at 24 h in both sexes
Two-way ANOVAs revealed significant main effects of ketamine treatment for both male and female mice [F(1,27) = 11.428, p = .003 and F(1,29) = 18.274, p < .001, respectively] ( Fig. 6a,b ; day 1). Further analysis revealed that ketamine decreased immobility in both control and CMS male mice (p = .05 and p = .023) and in control and CMS female mice (p = .042 and p < .001, respectively).
Long-lasting antidepressant-like effects of ketamine in the FST and the splash test were evident only in male CMS-exposed mice
Mice were subjected to a second FST at 7 days following ketamine treatment in order to screen for putative long-lasting effects in this test. A two way-ANOVA revealed a significant stress x drug interaction only in male mice [F(1,27) = 6.254, p =
.020]. Further analysis revealed that the long-lasting antidepressant-like effects of ketamine were still evident only in male CMS-exposed mice (p = .033; Fig. 6a,b ; day 7). Additionally, ketamine treatment induced sex-dependent effects in the splash test (Fig. 6c) . In particular, in male mice a two-way ANOVA revealed a significant stress 
Female mice are more sensitive to the antidepressant-like effects of ketamine in the FST
The FST is the most frequently used behavioral test for assessing the antidepressant-like effects of pharmacological agents in rodents (Cryan et al., 2002) and has been vastly used in the characterization of the antidepressant effects of ketamine in rodents (Browne and Lucki, 2013) . In our experimental setup, ketamine induced sex-dependent rapid (at 30 min) and sustained (at 24 h) antidepressant-like effects in the FST. In particular, female mice responded to lower doses of ketamine (i.e. 3 mg/kg at 30 min and 5 mg/kg at 24h), doses that were not effective in their male counterparts. Present results essentially replicate Carrier and Kabbaj's (β01γ) findings in another species. This higher female sensitivity to lower doses of ketamine in rodents is most likely gonadal hormone-dependent. Specifically, these authors reported that the rapid antidepressant-like effects of a low dose of ketamine (i.e. 2.5 mg/kg), that was effective only in female rats, were completely abolished in ovariectomized rats subjected to FST but emerged again upon restoration of physiological levels of estrogen and progesterone (Carrier and Kabbaj, 2013) . These data suggested an important role for sex hormones in enhancing the antidepressantlike effects of lower doses of ketamine in the female sex, but the innate mechanisms pertaining to these effects are still elusive.
Ketamine induces sex-dependent neurochemical effects in the HIPP and the PFC
Administration of an antidepressant-relevant dose of ketamine (i.e. 10 mg/kg) induced sex-differentiated and region-selective rapid alterations in the levels of excitatory amino acids glutamate and aspartate in the HIPP and the PFC, at 30 min post-injection. Herein we found that ketamine treatment reduced hippocampal glutamate concentrations in male mice in a sex-selective manner. Interestingly, administration of a high dose of ketamine (i.e. 100 mg/kg) has been previously reported to induce a rapid selective decrease of glutamate levels in the hippocampus of male Swiss albino mice at 30 min post-administration (Chatterjee et al., 2012) .
Importantly, the observed decrease in glutamate release could be associated with a hippocampus-selective ketamine-induced inhibition of presynaptic release machinery.
Upon this, it was recently shown that administration of a single sub-anesthetic dose of ketamine (15 mg/kg) in male Sprague-Dawley rats resulted in a rapid reduction in the accumulation of SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complexes in hippocampal synaptic membranes at 1 h post-ketamine administration, that is suggestive of a reduction of neurotransmitter release in the hippocampus (Muller et al., 2013) . Interestingly, our data in male mice is in agreement with Kavalali and Monteggia (2012) who suggested that ketamine-induced decrease in hippocampal glutamatergic activity may underlie the rapid antidepressant actions of ketamine. Indeed, these authors also suggest that screening for compounds that block the tonic and spontaneous glutamate presynaptic release could prove valuable in developing fast-acting antidepressants (Kavalali and Monteggia, 2012) .
Given that hippocampal glutamate concentrations were not altered in female mice it could be hypothesized that ketamine may impact hippocampal presynaptic release machinery and the expression of presynaptic proteins, in a sex-dependent manner.
Aspartate is the other major excitatory neurotransmitter of the brain that can excite neurons through selective activation of NMDARs (Curras and Dingledine, 1992) . In our study, ketamine induced a sex-specific increase of aspartate concentrations in the PFC of female but not male mice. Earlier studies have shown that both acute and chronic citalopram treatment resulted in diminished aspartate release in the rat PFC (Golembiowska and Dziubina, 2000) , while in a recent study chronic clomipramine and mirtazapine treatment reduced aspartate levels in the PFC of male but not female Sprague-Dawley rats (Kokras et al., 2009) . Given that the neurochemical effects of antidepressants on the brain's aspartate levels are poorly understood, the sex-differentiated pattern in response to ketamine exposed herein warrants further investigation.
At 24 h post-ketamine administration serotonergic activity in the PFC and the HIPP was found decreased in female mice. Interestingly, a battery of evidence strongly implicates the serotonergic system in the expression of sex-differentiated responsiveness to classical antidepressant drugs (Young et al., 2009 , Dalla et al., 2011 , Pitychoutis et al., 2012 , but it remains unclear as to whether the serotonergic system is involved in the rapid and/or sustained antidepressant-like effects of ketamine (Gigliucci et al., 2013) . Microdialysis studies have shown that ketamine administration induces a rapid increase of extracellular 5-HT in the medial PFC of male rodents (Nishitani et al., 2014) , and recently, Gigliucci et al. (2013) supported a role for serotonin in mediating the sustained antidepressant activity of ketamine in male rats subjected to FST. Still, the putative serotonergic mechanisms underlying the rapid and/or sustained antidepressant effects of ketamine remain to be elucidated (Duman et al., 2012 , Gigliucci et al., 2013 .
Taken together, our ex vivo neurochemical findings provide a "snapshot" of brain's chemistry at specific time-points and suggest that ketamine induces sexdependent and region-selective effects in the PFC and the HIPP. Indeed, these brain regions have been strongly implicated in sex-related neurobehavioral responses to stress and antidepressant treatments (Anderson et al., Carballedo et al., Groenewegen and Uylings, 2000 , Celada et al., 2004 , Drevets, 2007 , Pitychoutis et al., 2012 . Notably, this neurochemical profile could also reflect sexdependent kinetics in the regulation of excitatory amino acid release in the HIPP and the PFC. Future in vivo microdialysis studies in male and female cycling and/or gonadectomized mice are expected to shed light into the mechanisms implicated in this sex-differentiated neurochemical response. Despite the fact that a direct association between neurochemical alterations and behavioral data cannot be made herein, present findings are suggestive of ketamine-induced sex-dependent synaptic molecular events; whether these are directly or indirectly related to its antidepressant profile remains to be elucidated in future studies.
Sex-differentiated responsiveness to ketamine's antidepressant-like effects in mice exposed to the CMS model of depression
CMS produces a constellation of behavioral alterations in rodents thought to resemble core features of depressed patients, such as anhedonia or loss of grooming (Willner, 1997 (Willner, , 2005 ) and thus, is considered an ideal paradigm with which to screen the antidepressant-like effects of novel therapeutics like ketamine (Browne and Lucki, 2013) . Importantly, the CMS paradigm, despite its limitations, has been successfully employed to assess a constellation of interdisciplinary research questions in the sex differences field and has served as a 'silver bullet' in assessing the sexually dimorphic neurobiology of major depression and antidepressant response (for review see Franceschelli et al., 2014) .
In our study, ketamine treatment ( shortly following administration of antidepressant-relevant doses of ketamine (Engin et al., 2009 , Lindholm et al., 2012 , Browne and Lucki, 2013 , Gigliucci et al., 2013 , Ma et al., 2013 , Pozzi et al., 2014 . Interestingly in an earlier study conducted in male individually-housed Wistar rats, a low dose of ketamine (i.e. 7 mg/kg) was shown to induce anxiogenic-like effects in the elevated plus maze (Silvestre et al., 1997) . In our CMS study, both stressed and unstressed mice were also individually housed, thus an interaction between sex and social status pertaining to the actions of ketamine could be considered (Carrier and Kabbaj, 2013) . Surprisingly, ketamine induced a greater % decrease in FST immobility scores in CMS-exposed female versus male mice at 24 h post administration (47% vs 32%, as compared to their respective controls). Thus, these findings suggest that CMS-exposed females are more reactive to ketamine treatment at 30 min and at 24 h post-administration.
Intriguingly, the long-lasting antidepressant potential of ketamine was evidenced only in male CMS-exposed mice. Ketamine increased the time these mice spent grooming in the splash test (day 5) and reduced immobility duration in the FST (day 7) but did not exert relevant effects in females. Herein, the anti-anhedonic effects of ketamine were not observed at 6 days post-administration. Ketamine has been previously shown to induce a long-lasting (up to 7 days) reversal of CMS-induced anhedonia in rats and mice (Li et al., 2011 , Ma et al., 2013 , but this effect was not observed in other studies (Garcia et al., 2009 , Rezin et al., 2009 ). Interestingly, methodological differences regarding the assessment of anhedonia could explain the discrepancies reported herein such as testing duration (e.g. 1 h versus 15 h), prior food and water deprivation, assessment of sucrose intake versus sweet food consumption or even % of sucrose solution implemented. Moreover, ketamine was not effective in reversing the CMS-induced anxiogenic-like phenotype, as assessed in the marble burying test. It is likely that the time-points selected for screening for marble burying and sucrose intake behavior were not optimal. However, the antidepressant-like effects of ketamine in male mice were still evident in the splash test (day 5) and the FST (day 7). Overall, these data support the notion that the antidepressant-like effects of ketamine in stressed mice should not be considered as an "all-or-none" phenomenon but rather depend on the behavioral output measured (e.g. anhedonia in sucrose consumption test versus grooming in splash test).
Taken together, our behavioral findings suggest that CMS-exposed females are more reactive to the earlier effects of ketamine (i.e. at 30 min and at 24 h) but the antidepressant properties of this drug are longer-lasting in males and "wear-off" sooner in females. Given the short half-life of ketamine, the protracted behavioral effects measured days after administration result from rapid and sustained molecular alterations induced following a single ketamine injection (Browne and Lucki, 2013) .
In their landmark paper, Li et al. (2010) showed that the rapid antidepressant effects of a single dose of ketamine in male rats is mediated through the induction of synaptogenesis in the PFC, a brain region implicated in the pathophysiology of major depression (Li et al., 2010) . These new synapses are unstable and lost after several days, which coincide with relapse in depressed patients (Duman, 2014) . Thus, it is tempting to speculate that the sex-dependent reactivity and antidepressant time course of ketamine observed in CMS-exposed mice could reflect a sex-dependent time course of induction and maintenance of spine formation, a hypothesis that is currently under investigation.
Conclusions
In the present study we report that female C57BL/6J stress-naïve mice are more sensitive to the rapid and the sustained antidepressant-like effects of ketamine in the FST. Moreover, excitatory amino acid levels and serotonergic activity were affected in a sex-dependent manner in the HIPP and the PFC at 30 min or 24 h postketamine administration. Most importantly, ketamine induced sex-dependent behavioral effects in mice subjected to CMS. Intriguingly, female mice appeared to be more reactive to the earlier effects of ketamine (i.e. at 30 min and 24 h) but its antidepressant-like properties were longer-lasting in males (up to day 7). Further research in both naïve mice and in mice subjected to various animal models of depression is imperative in order for the intricate behavioral and neurobiological mechanisms underlying these sex differences to be elucidated.
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Figure 1: Experimental timeline of CMS paradigm: CMS procedures were performed for 5-weeks and then ketamine (10 mg/kg) or VEH were administered in male and female mice exposed to CMS or their respective controls. All mice were subsequently subjected to the behavioral tests as shown in the figure. Ketamine treatment reduced immobility in the FST in both control and CMS-exposed mice of both sexes on day 1. However, when these mice were re-tested in the FST on day 7 the antidepressant-like effects of ketamine were evidenced only in CMSexposed male mice (a,b). CMS reduced grooming duration in the splash test in both sexes but this was reversed by ketamine treatment only in male CMS-exposed mice 
